The European Medical Journal Presents: EMJ 4.3

London, United Kingdom, September 12, 2019

Our flagship journal has seen its third edition for 2019 published. European Medical Journal 4.3 contains a collection of thought-provoking, peer-reviewed papers, selected from the range of therapeutic areas that we cover: from hepatology to dermatology. We also take a look at the latest news in areas such as nephrology, urology, and haematology.

For rheumatologists, Day et al.’s paper ‘A Versatile, Low-Cost, Three-Dimensional-Printed Ultrasound Procedural Training Phantom of the Human Knee’ is an interesting read, as it considers the use of three-dimensional printed knee phantom as an option for training in musculoskeletal ultrasound. Additionally, Manzo and Emamifar look at the similarities between polymyalgia rheumatica and seronegative early-onset rheumatoid arthritis, in their paper: ‘Polymyalgia Rheumatica and Seronegative Elderly-Onset Rheumatoid Arthritis: Two Different Diseases with Many Similarities’.

Our allergy contribution to EMJ 4.3 is Chiera et al.’s paper, ‘Allergen-Specific Immunotherapy for Immunoglobulin E-Mediated Food Allergy’, takes a closer look at an increasingly popular therapeutic modality and its utilisation in the fight against food allergy: a potentially life-threatening condition which presents a significant health consideration worldwide, affecting up to 10% of the population.

This edition contains an exciting feature for those with a vested interested in in vitro fertilisation (IVF) add-on options, such as assisted hatching, physiological intracytoplasmic sperm injection, and embryo glue. Alteri et al.’s ‘The IVF Shopping List: To Tick or not to Tick’ delves into the options and looks at proposed classifications for each option, considering whether those undergoing IVF treatments should agree to these add-ons.

These are just a small selection of the fantastic papers and features available in EMJ 4.3, which also contains a range of symposium reviews, such as ‘Variability of Biologics and its Impact on Biosimilar Development’. Our flagship journal has something for everyone and this third edition for 2019 is not to be missed!

Notes to Editors

About EMJ:

Renowned for being the only medical journal to review the biggest European congresses, six weeks after each event is held, the European Medical Journal is an independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes, and advancements in the field.

Spanning sixteen therapeutic areas, including Innovations, Cardiology, Oncology, and more, each journal provides the reader with the latest from the field within our medical congress highlights, abstract reviews, and peer-reviewed articles to name but a few of its wide content selection. Flagship EMJ journals are also published quarterly, bringing an assortment of research and review papers from a variety of topics, alongside unique features and interviews. If you’re interested in receiving quarterly newsletters, and the latest publications straight to your inbox, please do subscribe for free: https://www.emjreviews.com/mailing-list/.

If you would like more information about this publication, please call Stacey Rivers at +44 (0) 1245 334450, or email [email protected].